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Is there no future for renal
BOLD-MRI?
To the Editor: We read with interest the recent article by
Michaely et al.1 in which it was stated that renal blood oxygen
level-dependent magnetic resonance imaging (BOLD-MRI) does
not reﬂect renal function in chronic kidney disease (CKD), a
conclusion that is in direct contrast to our recent results.2 We
strongly support the statement3 from the same issue that renal
tissue oxygenation appears to be dependent on CKD severity as
well as on the etiology of the underlying kidney disease. The
causes of chronic renal hypoxia are remarkably multifactorial,4
and while we have veriﬁed a relationship between BOLD-MRI
T2* values and estimated glomerular ﬁltration rates in non-
diabetic nephropathy, no association has been shown in cases of
diabetic nephropathy.2 Thus, etiological diversity in CKD might
have a far greater, and more pernicious, inﬂuence on BOLD-MRI
results than thought by Michaely et al. As the kidney is
surrounded by adipose tissue, removal of the out-of-phase
subtraction effect caused by this tissue is vital to minimizing
ﬂuctuations in T2* values. We, therefore, used in-phase echo time
(TE) of the longest possible duration to limit the T2* errors and
provide more accurate data, while balancing the signal-to-noise
ratio. Michaely et al. used an unusually short TE of just 40ms.
We, and other similarly focused groups, understand the
limitations of this novel modality and hope that the article does
not discourage the application of BOLD-MRI to CKD assessment.
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Limitations of BOLD-MRI for
assessment of hypoxia in
chronically diseased human kidneys
To the Editor: The article by Michaely et al.1 describes a
sizeable population of patients with chronic kidney disease
(CKD) with different degrees of severity of renal failure, in
which blood oxygen level–dependent magnetic resonance
imaging (BOLD-MRI) was used as a non-invasive technique
for monitoring the degree of renal oxygenation. This study
addressed the contention that intrarenal chronic hypoxia
underlies the progressive nature of most forms of CKD.2–4
The authors were unable to discriminate between patients
with different stages of CKD using this method.
We would argue that BOLD-MRI is not the appropriate
method for assessing oxygenation in CKD given the speciﬁc
evolution of the pathology in this setting. BOLD-MRI measures
vascular oxygen saturation with the signal being indirectly
related to deoxyhemoglobin concentration.5,6 To compare
different stages of disease for the degree of hypoxia, the volume
of the vessels and the number of red blood cells must be the
same in the voxels being compared, to make the comparison
valid. The patchy involvement of the chronically diseased
kidney, in which microvascular obliteration occurs in the
tubule-interstitial compartment, means that the expression of
a single datum point to reﬂect the entire cortex or medulla
(as portrayed in the paper by Michaely et al.) would fail to
capture this heterogeneity in the early and mid-stages of the
disease. Expressing the variability of the BOLD signal intensity
or R2* of pixels contained within the measured region of interest
for each patient may be a more appropriate way to detect
differences.
Equally important, in more advanced disease, both micro-
vasculature loss and a diminished red blood cell mass occur as
CKD progresses. Hence, the source of the signal for deoxyhe-
moglobin concentration in a volume being measured would
be diluted as the disease progresses, thereby obscuring
functionally relevant local hypoxic regions and making com-
parisons with less advanced disease invalid.
We concur with the author of the accompanying editorial
that ‘limitations in the technique and execution’ lead to the
conclusion that ‘the hypoxia hypothesis has not been refuted’.7
The study is important, however, for raising the need for
more reﬁned use of BOLD-MRI or for alternative methods for
determining intrarenal hypoxia in CKD.
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